Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Population mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996–2005

Authors: Marlous van Laar, Daniel P Stark, Patricia McKinney, Roger C Parslow, Sally E Kinsey, Susan V Picton, Richard G Feltbower

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Little aetiological epidemiological research has been undertaken for major cancers occurring in teenagers and young adults (TYA). Population mixing, as a possible proxy for infectious exposure, has been well researched for childhood malignancies. We aimed to investigate effects of population mixing in this older age group using an English national cancer dataset.

Methods

Cases of leukaemia, lymphoma and central nervous system (CNS) tumours amongst 15–24 year olds in England (diagnosed 1996–2005) were included in the study. Data were obtained by ward of diagnosis and linked to 1991 census variables including population mixing (Shannon index); data on person-weighted population density and deprivation (Townsend score) were also used and considered as explanatory variables. Associations between TYA cancer incidence and census variables were investigated using negative binomial regression, and results presented as incidence rate ratios (IRR) with 95% confidence intervals (CI).

Results

A total of 6251 cases of leukaemia (21%), lymphoma (49%) and CNS tumours (30%) were analysed. Higher levels of population mixing were associated with a significant decrease in the incidence of CNS tumours (IRR = 0.83, 95% CI = 0.75-0.91), accounted for by astrocytomas and ‘other CNS tumours’; however, there was no association with leukaemia or lymphoma. Incidence of CNS tumours and lymphoma was 3% lower in more deprived areas (IRR = 0.97, 95% CI = 0.96-0.99 and IRR = 0.97, 95% CI =0.96-0.98 respectively). Population density was not associated with the incidence of leukaemia, lymphoma or CNS tumours.

Conclusions

Our results suggest a possible role for environmental risk factors with population correlates in the aetiology of CNS tumours amongst TYAs. Unlike studies of childhood cancer, associations between population mixing and the incidence of leukaemia and lymphoma were not observed.
Literature
1.
Kinlen L: Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988, 332 (8624): 1323-1327. 10.1016/S0140-6736(88)90867-7.CrossRef
2.
Dickinson H, Hammal D, Bithell J, Parker L: Population mixing and childhood leukaemia and non-Hodgkin's lymphoma in census wards in England and Wales, 1966–87. Br J Cancer. 2002, 86 (9): 1411-1413. 10.1038/sj.bjc.6600275.CrossRefPubMedPubMedCentral
3.
Law GR, Parslow RC, Roman E: Childhood cancer and population mixing. Am J Epidemiol. 2003, 158 (4): 328-336. 10.1093/aje/kwg165.CrossRefPubMed
4.
Greaves M: Aetiology of acute leukaemia. Lancet. 1997, 349 (9048): 344-349. 10.1016/S0140-6736(96)09412-3.CrossRefPubMed
5.
Anderson RM, May R: Immunisation and herd immunity. Lancet. 1990, 335 (8690): 641-645. 10.1016/0140-6736(90)90420-A.CrossRefPubMed
6.
Parslow RC, Law GR, Feltbower R, Kinsey SE, McKinney PA: Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire. Eur J Cancer. 2002, 38 (15): 2033-2040. 10.1016/S0959-8049(02)00316-7.CrossRefPubMed
7.
Basta NO, James PW, Craft AW, McNally RJQ: Season of birth and diagnosis for childhood cancer in Northern England, 1968–2005. Paediatr Perinat Epidemiol. 2010, 24 (3): 309-318. 10.1111/j.1365-3016.2010.01112.x.CrossRefPubMed
8.
McNally RJQ, Eden TOB: An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol. 2004, 127 (3): 243-263. 10.1111/j.1365-2141.2004.05166.x.CrossRefPubMed
9.
Simpson J, Smith A, Ansell P, Roman E: Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer. 2007, 43 (16): 2396-2403. 10.1016/j.ejca.2007.07.027.CrossRefPubMed
10.
Chang JS, Tsai C-R, Tsai Y-W, Wiemels JL: Medically diagnosed infections and risk of childhood leukaemia: a population-based case–control study. Int J Epidemiology. 2012, 41 (4): 1050-1059. 10.1093/ije/dys113.CrossRef
11.
Stiller C, Kroll M, Boyle P, Feng Z: Population mixing, socioeconomic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales: analysis by census ward. Br J Cancer. 2008, 98 (5): 1006-1011. 10.1038/sj.bjc.6604237.CrossRefPubMedPubMedCentral
12.
Hjalgrim H, Engels E: Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008, 264 (6): 537-548. 10.1111/j.1365-2796.2008.02031.x.CrossRefPubMed
13.
McNally RJQ, Stiller C, Vincent TJ, Murphy MFG: Cross-space-time clustering of childhood cancer in Great Britain: Evidence for a common aetiology. Int J Cancer. 2014, 134 (1): 136-143. 10.1002/ijc.28332.CrossRefPubMed
14.
McNally RJ, James PW, Picton SV, McKinney PA, van Laar M, Feltbower RG: Space-time clustering of childhood central nervous system tumours in Yorkshire, UK. BMC Cancer. 2012, 12 (1): 13-10.1186/1471-2407-12-13.CrossRefPubMedPubMedCentral
15.
Ortega-García JA, López-Hernández FA, Fuster-Soler JL, Martínez-Lage JF: Space–time clustering in childhood nervous system tumors in the Region of Murcia, Spain, 1998–2009. Childs Nerv Syst. 2011, 27 (11): 1903-1911. 10.1007/s00381-011-1483-0.CrossRefPubMed
16.
Schmidt L, Grell K, Frederiksen K, Johansen C, Schmiegelow K, Schüz J: Seasonality of birth in children with central nervous system tumours in Denmark, 1970–2003. Br J Cancer. 2009, 100 (1): 185-187. 10.1038/sj.bjc.6604813.CrossRefPubMed
17.
McNally RJ, Alston RD, Eden TO, Kelsey AM, Birch JM: Further clues concerning the aetiology of childhood central nervous system tumours. Eur J Cancer. 2004, 40 (18): 2766-2772. 10.1016/j.ejca.2004.08.020.CrossRefPubMed
18.
Harding N, Birch J, Hepworth S, McKinney P: Infectious exposure in the first year of life and risk of central nervous system tumors in children: analysis of day care, social contact, and overcrowding. Cancer Causes Control. 2009, 20 (2): 129-136. 10.1007/s10552-008-9224-8.CrossRefPubMed
19.
McNally RJQ: Are early infectious exposures involved in the etiology of childhood CNS tumors?. Expert Rev Neurother. 2010, 10 (11): 1663-1665. 10.1586/ern.10.157.CrossRefPubMed
20.
Schmidt L, Kamper-Jørgensen M, Schmiegelow K, Johansen C, Lähteenmäki P, Träger C, Stokland T, Grell K, Gustafson G, Kogner P: Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth. Br J Cancer. 2010, 102 (11): 1670-1675. 10.1038/sj.bjc.6605679.CrossRefPubMedPubMedCentral
21.
Birch JM, Alston RD, Quinn M, Kelsey AM: Incidence of malignant disease by morphological type, in young persons aged 12–24 years in England, 1979–1997. Eur J Cancer. 2003, 39 (18): 2622-2631. 10.1016/j.ejca.2003.08.006.CrossRefPubMed
22.
Bleyer WA: Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002, 38: 1-10. 10.1002/mpo.1257.CrossRefPubMed
23.
Alston RD, Rowan S, Eden TOB, Moran A, Birch JM: Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England. Br J Cancer. 2007, 96: 1760-1766. 10.1038/sj.bjc.6603794.CrossRefPubMedPubMedCentral
24.
Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJQ: Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer. 2002, 87 (11): 1267-10.1038/sj.bjc.6600647.CrossRefPubMedPubMedCentral
25.
van Laar M, Kinsey SE, Picton SV, Feltbower RG: First description of seasonality of birth and diagnosis amongst teenagers and young adults aged 15–24 with cancer in England, 1996–2005. BMC Cancer. 2013, 13: 365-374. 10.1186/1471-2407-13-365.CrossRefPubMedPubMedCentral
26.
Rhodes C, Anderson R: Persistence and dynamics in lattice models of epidemic spread. J Theor Biol. 1996, 180 (2): 125-133. 10.1006/jtbi.1996.0088.CrossRefPubMed
27.
Miller GA: Note on the bias of information estimates. Inf Theory Psychol. 1955, 2: 95-100.
28.
Office of Population Censuses and Surveys: Census: special migration statistics (Great Britain). ESRC/JISC Census Programme. 1991
29.
Dorling D, Atkins D, Office of Population Censuses & Surveys [OPCS]: Population density, change and concentration in Great Britain 1971, 1981 and 1991. Studies on Medical & Population Subjects No. 58. 1995, London: HM Stationery Office
30.
Townsend P, Phillimore P, Beattie A: Health and deprivation: inequality and the North. 1988, London: Croom Helm
31.
Akaike H: Information theory and an extension of the maximum likelihood principle. Second International Symposium on Information Theory. Edited by: Petrov BN, Czàke F. 1973, Budapest: Akademiai Kiadó
32.
Feltbower RG, Manda SOM, Gilthorpe MS, Greaves MF, Parslow RC, Kinsey SE, Bodansky HJ, McKinney PA: Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach. Am J Epidemiol. 2005, 161 (12): 1168-1180. 10.1093/aje/kwi146.CrossRefPubMed
33.
McKinney P, Alexander F, Cartwright R, Scott C, Staines A: Acute lymphoblastic leukaemia incidence in the UK by immunophenotype. Leukemia. 1993, 7 (10): 1630-1634.PubMed
34.
Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G, Ferrando A, Fielding AK, Goldstone AH, Ketterling RP: T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood. 2009, 114 (25): 5136-5145. 10.1182/blood-2009-08-231217.CrossRefPubMedPubMedCentral
35.
Greaves MF, Janossy G, Peto J, Kay H: Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol. 1981, 48: 179-197. 10.1111/j.1365-2141.1981.tb02704.x.CrossRefPubMed
36.
Taylor JC, Law GR, Boyle PJ, Feng Z, Gilthorpe MS, Parslow RC, Rudge G, Feltbower RG: Does population mixing measure infectious exposure in children at the community level?. Eur J Epidemiol. 2008, 23 (9): 593-600. 10.1007/s10654-008-9272-0.CrossRefPubMed
37.
38.
McNally R, Cairns D, Eden O, Alexander F, Taylor G, Kelsey A, Birch J: An infectious aetiology for childhood brain tumours? Evidence from space–time clustering and seasonality analyses. Br J Cancer. 2002, 86 (7): 1070-1077. 10.1038/sj.bjc.6600228.CrossRefPubMedPubMedCentral
39.
Love S, Louis DN, Ellison D: Greenfield’s neuropathology. 2008, Boca Raton: CRC Press, 8
40.
Piantadosi S, Byar DP, Green SB: The ecological fallacy. Am J Epidemiol. 1988, 127 (5): 893-904.PubMed
Metadata
Title
Population mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996–2005
Authors
Marlous van Laar
Daniel P Stark
Patricia McKinney
Roger C Parslow
Sally E Kinsey
Susan V Picton
Richard G Feltbower
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-698

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue

Research article

Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma

Research article

Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma

Research article

Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer

Research article

Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response

Research article

Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner

Research article

Comparison of two threshold detection criteria methodologies for determination of probe positivity for intraoperative in situ identification of presumed abnormal 18F-FDG-avid tissue sites during radioguided oncologic surgery
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits